Health Care: Drugs

Cambrex Corp (CBM: NYSE)

$46.6 n/a | n/a%
09/23/16 - 04:02 PM ET
Company Profile
Price and Volume
Recent Price 46.60
52 Week High 59.41
52 Week Low 29.50
Avg. Daily Vol. (Mil) 0.41
Beta (3 year) 2.40
Share Related Items
Mkt Cap (Mil) 1,498.06
Shares Out (Mil) 32.15
Float (Mil) 33.01
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.40
Current Ratio 2.70
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 23.80
Price/Sales 3.31
Price/Book 4.47
Price/Cash Flow 17.40
Per Share Data
Earnings 1.96
Sales 14.08
Book Value 10.42
Cash Flow 2.68
Business Summary
Cambrex Corp is a life sciences company. It provides products and services that accelerate and improve the development and commercialization of new and generic therapeutics.
General Information
One Meadowlands Plaza
East Rutherford, NJ 07073
Industry : Drugs
Sector: Health Care
Employees: 1228
CEO: Steven M. Klosk
Short Interest
Current Month (Mil) 2.26
Previous Month (Mil) 2.46
Short Interest Ratio (Days) 5.60
Management Effectiveness
Return on Equity 19.00
Return on Assets 11.70
Return on Investments 19.00
Gross Margin 46.70
EBIT Margin 21.90
Profit Margin 14.10

Portfolios with CBM

Latest CBM Headlines from TheStreet

More Financial News for CBM

Press Releases for CBM

See All Press Releases

Partner Headlines for CBM

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter